FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 339:1775-1777 December 10, 1998 Number 24 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Lo, Y.M. D. PubMed Citation

Hemolytic disease of the fetus and newborn was first described in 1609 in a set of twins by a French midwife: the first twin was hydropic and stillborn, and the second was deeply jaundiced and subsequently died of what we now call kernicterus. The two conditions were not associated again until 1932, when Diamond et al. demonstrated that hydrops and kernicterus were two aspects of the same disease in which hemolysis of the red cells of fetuses and neonates resulted in extramedullary erythropoiesis, causing hepatosplenomegaly and an outpouring of erythroblasts into the circulation, a condition they termed erythroblastosis fetalis.¹ Kernicterus . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Maayan-Metzger, A, Schwartz, T, Sulkes, J, Merlob, P (2001). Maternal anti-D prophylaxis during pregnancy does not cause neonatal haemolysis. Arch. Dis. Child. Fetal Neonatal Ed. 84: 60F-62 [Abstract] [Full Text]